197 related articles for article (PubMed ID: 1518837)
1. Mutants of complement component C3 cleaved by the C4-specific C1-s protease.
Mathias P; Carrillo CJ; Zepf NE; Cooper NR; Ogata RT
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8125-9. PubMed ID: 1518837
[TBL] [Abstract][Full Text] [Related]
2. Complement component C5: engineering of a mutant that is specifically cleaved by the C4-specific C1s protease.
Ogata RT; Low PJ
J Immunol; 1995 Sep; 155(5):2642-51. PubMed ID: 7650393
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificities of the protease of mouse serum Ra-reactive factor.
Ogata RT; Low PJ; Kawakami M
J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903
[TBL] [Abstract][Full Text] [Related]
4. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
Sandoval A; Ai R; Ostresh JM; Ogata RT
J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
[TBL] [Abstract][Full Text] [Related]
5. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.
Ebanks RO; Isenman DE
Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451
[TBL] [Abstract][Full Text] [Related]
6. Murine complement component C4 and sex-limited protein: identification of amino acid residues essential for C4 function.
Ogata RT; Cooper NR; Bradt BM; Mathias P; Picchi MA
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5575-9. PubMed ID: 2748603
[TBL] [Abstract][Full Text] [Related]
7. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
Low PJ; Ai R; Ogata RT
J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
[TBL] [Abstract][Full Text] [Related]
8. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.
Vorup-Jensen T; Jensenius JC; Thiel S
Immunobiology; 1998 Aug; 199(2):348-57. PubMed ID: 9777418
[TBL] [Abstract][Full Text] [Related]
9. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
10. Substrate specificities of murine C1s.
Ogata RT; Low PJ; Bradt BM; Cooper NR
J Immunol; 1994 Jun; 152(12):5890-5. PubMed ID: 8207214
[TBL] [Abstract][Full Text] [Related]
11. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
Inal JM; Schifferli JA
J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
[TBL] [Abstract][Full Text] [Related]
12. Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b.
von Zabern I; Nolte R; Vogt W
Scand J Immunol; 1981; 13(5):413-31. PubMed ID: 6171865
[TBL] [Abstract][Full Text] [Related]
13. Functional role of the linker between the complement control protein modules of complement protease C1s.
Bally I; Rossi V; Thielens NM; Gaboriaud C; Arlaud GJ
J Immunol; 2005 Oct; 175(7):4536-42. PubMed ID: 16177097
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.
Avirutnan P; Fuchs A; Hauhart RE; Somnuke P; Youn S; Diamond MS; Atkinson JP
J Exp Med; 2010 Apr; 207(4):793-806. PubMed ID: 20308361
[TBL] [Abstract][Full Text] [Related]
15. Identification of a catalytic exosite for complement component C4 on the serine protease domain of C1s.
Duncan RC; Mohlin F; Taleski D; Coetzer TH; Huntington JA; Payne RJ; Blom AM; Pike RN; Wijeyewickrema LC
J Immunol; 2012 Sep; 189(5):2365-73. PubMed ID: 22855709
[TBL] [Abstract][Full Text] [Related]
16. Third component of trout complement. cDNA cloning and conservation of functional sites.
Lambris JD; Lao Z; Pang J; Alsenz J
J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
[TBL] [Abstract][Full Text] [Related]
17. Native conformations of human complement components C3 and C4 show different dependencies on thioester formation.
Isaac L; Aivazian D; Taniguchi-Sidle A; Ebanks RO; Farah CS; Florido MP; Pangburn MK; Isenman DE
Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):705-12. PubMed ID: 9445402
[TBL] [Abstract][Full Text] [Related]
18. Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate.
Rossi V; Bally I; Thielens NM; Esser AF; Arlaud GJ
J Biol Chem; 1998 Jan; 273(2):1232-9. PubMed ID: 9422791
[TBL] [Abstract][Full Text] [Related]
19. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
Gigli I; Fujita T; Nussenzweig V
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
